MORE Promising news for PSC research!
New SPRING trial data shows Nebokitug remains safe and continues to improve inflammation & scarring after 48 weeks.
Next step: Phase 3 trial 🙌
ℹ️ pscsupport.org.uk/spring-clini...
#LetsBeatPSC #PSCSupport #Nebokitug #LiverResearch #ClinicalTrials

Encouraging news for the PSC community! 🌟 Positive results from Chemomab's Phase 2 trial of #Nebokitug show promise for PSC treatment. Read more: pscsupport.org.uk/chemomab-rep... #LetsBeatPSC